Our Alzheimer's drug was not a complete bust, says vTv; Xtalpi raises $46M more for AI drug discovery engine
→ Still recovering from the hammering it took on the failure of its Alzheimer’s drug, little vTv $VTVT is pushing out post hoc analysis on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
